Doctors largely comfortable with biosimilar drugs, but question economics: report

Doctors largely comfortable with biosimilar drugs, but question economics: report

Source: 
BioPharma Dive
snippet: 

By and large, doctors appear to be comfortable prescribing biosimilar drugs, the copycat version of biologic medicines like inflammatory disease drug Humira or eye treatment Lucentis. But they aren’t yet sure the discounts offered are enough to justify switching patients who are stable on the brand-name products, according to an annual report from healthcare distributor Cardinal Health released Wednesday.